PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.97%
Revenue growth similar to NXPI's 3.21%. Walter Schloss would see if both companies share industry tailwinds.
4.03%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
16.31%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
12.45%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
207.84%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
204.00%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
200.00%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
4.94%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
5.32%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-7.43%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
59.20%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
136.40%
FCF growth 1.25-1.5x NXPI's 94.26%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
36.04%
10Y revenue/share CAGR under 50% of NXPI's 79.10%. Michael Burry would suspect a lasting competitive disadvantage.
-23.23%
Negative 5Y CAGR while NXPI stands at 77.31%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-0.63%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
277.93%
10Y OCF/share CAGR above 1.5x NXPI's 104.58%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
42.76%
Below 50% of NXPI's 107.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-5.23%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
8874.99%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
307.63%
5Y net income/share CAGR similar to NXPI's 328.95%. Walter Schloss might see both on parallel mid-term trajectories.
365.54%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
292.02%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
211.37%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
153.92%
3Y equity/share CAGR above 1.5x NXPI's 42.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
7.92%
Dividend/share CAGR of 7.92% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
29.26%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-7.85%
Negative near-term dividend growth while NXPI invests at 20.43%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.79%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.75%
Inventory growth well above NXPI's 0.47%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
11.76%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.81%
BV/share growth above 1.5x NXPI's 3.20%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.82%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.25%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
3.09%
We expand SG&A while NXPI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.